These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38292054)

  • 21. Delayed versus standard assessment for excision surgery in patients with Buruli ulcer in Benin: a randomised controlled trial.
    Wadagni AC; Barogui YT; Johnson RC; Sopoh GE; Affolabi D; van der Werf TS; de Zeeuw J; Kleinnijenhuis J; Stienstra Y
    Lancet Infect Dis; 2018 Jun; 18(6):650-656. PubMed ID: 29605498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nutritional status and wound healing in patients with Mycobacterium ulcerans disease (Buruli ulcer): a pilot study from rural Côte d’Ivoire.
    Ugai K; Koffi DY; Kouadio K; Yao A; Yotsu RR
    Eur J Dermatol; 2022 Apr; 32(2):227-236. PubMed ID: 35866902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin.
    Johnson RC; Sáez-López E; Anagonou ES; Kpoton GG; Ayelo AG; Gnimavo RS; Mignanwande FZ; Houezo JG; Sopoh GE; Addo J; Orford L; Vlasakakis G; Biswas N; Calderon F; Della Pasqua O; Gine-March A; Herrador Z; Mendoza-Losana A; Díez G; Cruz I; Ramón-García S
    Trials; 2022 Jul; 23(1):559. PubMed ID: 35804454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of human immunodeficiency virus on the severity of buruli ulcer disease: results of a retrospective study in cameroon.
    Christinet V; Comte E; Ciaffi L; Odermatt P; Serafini M; Antierens A; Rossel L; Nomo AB; Nkemenang P; Tsoungui A; Delhumeau C; Calmy A
    Open Forum Infect Dis; 2014 Mar; 1(1):ofu021. PubMed ID: 25734094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing Buruli ulcer control in Ghana through social interventions: a case study from the Obom sub-district.
    Ahorlu CK; Koka E; Yeboah-Manu D; Lamptey I; Ampadu E
    BMC Public Health; 2013 Jan; 13():59. PubMed ID: 23339623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Outcome of Patients with Buruli Ulcer Disease in Togo.
    Beissner M; Arens N; Wiedemann F; Piten E; Kobara B; Bauer M; Herbinger KH; Badziklou K; Banla Kere A; Löscher T; Nitschke J; Bretzel G
    PLoS Negl Trop Dis; 2015; 9(10):e0004170. PubMed ID: 26474069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persisting social participation restrictions among former Buruli ulcer patients in Ghana and Benin.
    de Zeeuw J; Omansen TF; Douwstra M; Barogui YT; Agossadou C; Sopoh GE; Phillips RO; Johnson C; Abass KM; Saunderson P; Dijkstra PU; van der Werf TS; Stienstra Y
    PLoS Negl Trop Dis; 2014 Nov; 8(11):e3303. PubMed ID: 25392915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of patient and wound variables on healing of venous leg ulcers in a randomized controlled trial of growth-arrested allogeneic keratinocytes and fibroblasts.
    Lantis JC; Marston WA; Farber A; Kirsner RS; Zhang Y; Lee TD; Cargill DI; Slade HB
    J Vasc Surg; 2013 Aug; 58(2):433-9. PubMed ID: 23588112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with
    Loglo AD; Frimpong M; Sarpong Duah M; Sarfo F; Sarpong FN; Agbavor B; Boakye-Appiah JK; Abass KM; Dongyele M; Frempong M; Pidot S; Wansbrough-Jones M; Stinear TP; Roupie V; Huygen K; Phillips RO
    PeerJ; 2018; 6():e5294. PubMed ID: 30090691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mental health and quality of life burden in Buruli ulcer disease patients in Ghana.
    Amoako YA; Ackam N; Omuojine JP; Oppong MN; Owusu-Ansah AG; Boateng H; Abass MK; Amofa G; Ofori E; Okyere PB; Frimpong M; Bailey F; Molyneux DH; Phillips RO
    Infect Dis Poverty; 2021 Aug; 10(1):109. PubMed ID: 34404483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression.
    Nausch N; Antwi-Berko D; Mubarik Y; Abass KM; Owusu W; Owusu-Dabo E; Debrah LB; Debrah AY; Jacobsen M; Phillips RO
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005415. PubMed ID: 28241036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards rational use of antibiotics for suspected secondary infections in Buruli ulcer patients.
    Barogui YT; Klis S; Bankolé HS; Sopoh GE; Mamo S; Baba-Moussa L; Manson WL; Johnson RC; van der Werf TS; Stienstra Y
    PLoS Negl Trop Dis; 2013; 7(1):e2010. PubMed ID: 23359827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulcerans infections.
    O'Brien DP; Robson M; Friedman ND; Walton A; McDonald A; Callan P; Hughes A; Rahdon R; Athan E
    BMC Infect Dis; 2013 Sep; 13():416. PubMed ID: 24007371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management.
    Velink A; Woolley RJ; Phillips RO; Abass KM; van der Werf TS; Agumah E; de Zeeuw J; Klis S; Stienstra Y
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005261. PubMed ID: 28033343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers.
    Li Z; Guo S; Yao F; Zhang Y; Li T
    J Diabetes Complications; 2013; 27(4):380-2. PubMed ID: 23357650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychometric properties of the participation scale among former buruli ulcer patients in Ghana and Benin.
    de Zeeuw J; Douwstra M; Omansen TF; Sopoh GE; Johnson C; Phillips RO; Alferink M; Saunderson P; Van der Werf TS; Dijkstra PU; Stienstra Y
    PLoS Negl Trop Dis; 2014; 8(11):e3254. PubMed ID: 25393289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paradoxical responses after start of antimicrobial treatment in Mycobacterium ulcerans infection.
    Nienhuis WA; Stienstra Y; Abass KM; Tuah W; Thompson WA; Awuah PC; Awuah-Boateng NY; Adjei O; Bretzel G; Schouten JP; van der Werf TS
    Clin Infect Dis; 2012 Feb; 54(4):519-26. PubMed ID: 22156855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT.
    Gohel MS; Heatley F; Liu X; Bradbury A; Bulbulia R; Cullum N; Epstein DM; Nyamekye I; Poskitt KR; Renton S; Warwick J; Davies AH
    Health Technol Assess; 2019 May; 23(24):1-96. PubMed ID: 31140402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenolic glycolipid-1 (PGL-1) in Buruli ulcer lesions. First demonstration by immuno-histochemistry.
    Mwanatambwe M; Yajima M; Etuaful S; Fukunishi Y; Suzuki K; Asiedu K; Yamada N; Asanao G
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):201-5. PubMed ID: 12483968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buruli ulcer treatment: Rate of surgical intervention differs highly between treatment centers in West Africa.
    Wadagni AC; Steinhorst J; Barogui YT; Catraye PM; Gnimavo R; Abass KM; Amofa G; Frimpong M; Sarpong FN; van der Werf TS; Phillips R; Sopoh GE; Johnson CR; Stienstra Y
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007866. PubMed ID: 31658295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.